Sustainability Report

Overview

The report is Pharmesis International Ltd.'s first sustainability report for FY2017. It describes a GRI-based materiality process that prioritised Economic Performance, Product Quality and Safety, and Occupational Health and Safety. Board oversight and a CEO-led Sustainability Steering Committee are described, while 2017 total revenue was RMB 69.7 million.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2017
Period: Ends 31 December 2017
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Ratings

GRI level

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services